ORAL PIRITREXIM IN ADVANCED BLADDER-CANCER - AN EFFECTIVE DRUG AFTER PROGRESSION ON MVAC CHEMOTHERAPY

被引：12

作者：

FEUN, LG ^{[1
]}

SAVARAJ, N ^{[1
]}

BENEDETTO, P ^{[1
]}

WALDMAN, S ^{[1
]}

COLLIER, M ^{[1
]}

CLENDENNIN, NJ ^{[1
]}

机构：

[1] BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1994年 / 17卷 / 05期

关键词：

ORAL PIRITREXIM; BLADDER CANCER;

D O I：

10.1097/00000421-199410000-00019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.

引用

页码：448 / 451

页数：4

共 6 条

[1] ORAL PIRITREXIM, AND EFFECTIVE TREATMENT FOR METASTATIC UROTHELIAL CANCER
DEWIT, R
KAYE, SB
ROBERTS, JT
STOTER, G
SCOTT, J
VERWEIJ, J
[J]. BRITISH JOURNAL OF CANCER, 1993, 67 (02) : 388 - 390
[2] DUCH DS, 1982, CANCER RES, V42, P3987
[3] PHASE-I TRIAL OF PIRITREXIM CAPSULES USING PROLONGED, LOW-DOSE ORAL-ADMINISTRATION FOR THE TREATMENT OF ADVANCED MALIGNANCIES
FEUN, LG
SAVARAJ, N
BENEDETTO, P
HANLON, J
SRIDHAR, KS
COLLIER, M
RICHMAN, S
LIAO, SH
CLENDENINN, NJ
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (01) : 51 - 55
[4] HUSSEIN AM, 1989, J NEURO-ONCOL, V7, P255
[5] SEDWICK WD, 1982, MOL PHARMACOL, V22, P766
[6] Stein S, 1987, Compr Gerontol B, V1, P41

← 1 →